Wedbush Initiates Coverage On Korsana Biosciences with Outperform Rating, Announces Price Target of $44
Wedbush analyst Laura Chico initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Outperform rating and announces Price Target of $44.
Stocks · News reference
Stifel Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $43
Stifel analyst Paul Matteis initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Buy rating and announces Price Target of $43.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Guggenheim Initiates Coverage On Korsana Biosciences with Buy Rating, Announces Price Target of $70
Guggenheim analyst Yatin Suneja initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Buy rating and announces Price Target of $70.
TD Cowen Initiates Coverage On Korsana Biosciences with Buy Rating
TD Cowen analyst Tyler Van Buren initiates coverage on Korsana Biosciences (NASDAQ:KRSA) with a Buy rating.